. . . . . . . . . "lucentis is indicated for the treatment of patients with lucentis a vascular endothelial growth factor vegf inhibitor is indicated for the treatment of patients with neovascular wet age related macular degeneration amd 1 1 macular edema following retinal vein occlusion rvo 1 2 diabetic macular edema dme 1 3 diabetic retinopathy dr 1 4 myopic choroidal neovascularization mcnv 1 5" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "iUTGnqIysUkRjeKNXrcraQPCTSSXTOOAox/erxIwWH0oXLeIE0x9IgggRvrc7h540/eSx7UoWFvldBRzziSQohMMGLaiZJZUc7omISA2vlhK0TBnu5TP5STjA/lFkWfkdB0GkfwXjnN/AjxTq8fZuK18Us9Q9Hg0r8V9Q+T4lPU=" . . "2021-07-03T15:14:13.406+02:00"^^ . . . . .